<SEC-DOCUMENT>0000950170-23-005084.txt : 20230228
<SEC-HEADER>0000950170-23-005084.hdr.sgml : 20230228
<ACCEPTANCE-DATETIME>20230228161101
ACCESSION NUMBER:		0000950170-23-005084
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230228
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230228
DATE AS OF CHANGE:		20230228

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Arcus Biosciences, Inc.
		CENTRAL INDEX KEY:			0001724521
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				473898435
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38419
		FILM NUMBER:		23685332

	BUSINESS ADDRESS:	
		STREET 1:		3928 POINT EDEN WAY
		CITY:			HAYWARD
		STATE:			CA
		ZIP:			94545
		BUSINESS PHONE:		(510) 694-6200

	MAIL ADDRESS:	
		STREET 1:		3928 POINT EDEN WAY
		CITY:			HAYWARD
		STATE:			CA
		ZIP:			94545
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>rcus-20230228.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?><!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2023-02-28T15:54:08.2625+00:00 --><!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:rcus="http://arcusbio.com/20230228">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html" />
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_376ebc41-c3a9-4a1b-b5dd-5a5ac30bb478" name="dei:AmendmentFlag" contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c">false</ix:nonNumeric><ix:nonNumeric id="F_72021a59-91a5-44b2-a3e9-aec87a77cd4d" name="dei:EntityCentralIndexKey" contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c">0001724521</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="rcus-20230228.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C_df0de228-4cd4-4905-a604-0c5db05d905c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001724521</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-28</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <p style="border-top:2.25pt double rgba(0,0,0,1);text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">UNITED STATES<br />SECURITIES AND EXCHANGE COMMISSION<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FORM </span><span style="font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_6534ed74-9d1d-42c2-9130-786096a7abfa" contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c" name="dei:DocumentType"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CURRENT REPORT</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.02986111111111111in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a990aa1f-07ce-49ee-ba02-ecc46b7ba072" contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">February 28, 2023</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:5.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:24.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_713aa355-3333-4ede-b612-259e9760613b" contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c" name="dei:EntityRegistrantName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:24.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Arcus Biosciences, Inc.</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:20.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:20.0%;"></td>
    <td style="width:18.0%;"></td>
    <td style="width:41.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1c073011-e8d4-4acf-a57e-3c10a85c4d6e" contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_10ad603a-ab8a-45d6-9691-0aef2320fb75" contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c" name="dei:EntityFileNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">001-38419</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b8284580-b402-4432-b01e-50bfaafcf9e1" contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c" name="dei:EntityTaxIdentificationNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47-3898435</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(State or Other Jurisdiction<br />of Incorporation)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Commission File Number)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(IRS Employer<br />Identification No.)</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9fad0802-319b-4e28-ae57-cfe47a6d1289" contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c" name="dei:EntityAddressAddressLine1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3928 Point Eden Way</span></ix:nonNumeric></span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d652d015-db40-4fda-8ddf-c5c08fd28b15" contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c" name="dei:EntityAddressCityOrTown"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Hayward</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5a48de26-8b01-43b5-a95f-c6def6a1666c" contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">California</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_aa2994bc-390a-44f6-a3b8-78e49968c740" contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c" name="dei:EntityAddressPostalZipCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">94545</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.125in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.02986111111111111in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registrant&#x2019;s Telephone Number, Including Area Code:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_55592e08-7811-4cb0-a3c0-bd75e4672bdd" contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c" name="dei:CityAreaCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(510)</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_57f07c3e-7d64-46ca-a628-82233055c2b4" contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c" name="dei:LocalPhoneNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">694-6200</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.125in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:9.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a29ae567-a275-4a1e-a7b1-609750ce0467" contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c861aeef-9b1b-4f0c-8df1-a507b9fea128" contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_289e2376-110c-400a-8706-d539a44faa82" contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ebd88478-02bc-4d4e-8823-86fc0a920fe8" contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:9.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:38.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:15.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:45.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:1px solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br />Title of each class</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.011pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:1px solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trading<br />Symbol(s)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.011pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:1px solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br />Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_09c6f262-c435-4c1d-95b3-da753fa8b488" contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c" name="dei:Security12bTitle"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock, Par Value $0.0001 Per Share</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d4e2a01f-1439-4744-9d06-6ecfb7159a64" contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c" name="dei:TradingSymbol"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RCUS</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_4d97c5fb-cb2e-42b1-af6a-d0e4017dd05d" contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The New York Stock Exchange</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#x202f;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#x202f;240.12b-2 of this chapter).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Emerging growth company </span><span style="font-size:10.0pt;"><ix:nonNumeric id="F_c89bfc35-e03d-43b3-91de-17034fe87d93" contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:2.25pt double rgba(0,0,0,1);text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 2.02 Results of Operations and Financial Condition.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On February 28, 2023, Arcus Biosciences, Inc. issued a press release announcing its financial results for the three months and full year ended December 31, 2022. The full text of the press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information in this Item 2.02 of this Form 8-K (including Exhibit 99.1) is intended to be furnished and shall not be deemed &#x201c;filed&#x201d; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#x201c;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exchange Act</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended or the Exchange Act, except as expressly set forth by specific reference in such filing.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d) Exhibits.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:9.62%;"></td>
    <td style="width:2.519%;"></td>
    <td style="width:87.861%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:1pt solid rgba(0,0,0,1);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit No.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:1pt solid rgba(255,255,255,0.01);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid rgba(0,0,0,1);text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:12.4pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">99.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="rcus-ex99_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Press release dated February 28, 2023.</span><span style="color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></a></p></td>
   </tr>
   <tr style="height:12.4pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL Document)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SIGNATURES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:56.556%;"></td>
    <td style="width:1.157%;"></td>
    <td style="width:3.343%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:37.944%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ARCUS BIOSCIENCES, INC.</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: February 28, 2023</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:1pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Terry Rosen, Ph. D.</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Terry Rosen, Ph.D.</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Executive Officer</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Principal Executive Officer)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>rcus-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Exhibit 99.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img230044022_0.jpg" alt="img230044022_0.jpg" style="width:149px;height:52px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Arcus Biosciences Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides a Pipeline Update</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;font-style:italic;min-width:fit-content;">At the American Society of Clinical Oncology (ASCO) Plenary session in December 2022, interim data were presented from the ARC-7 study, which demonstrated a median PFS of ~12.0 months for domvanalimab plus zimberelimab vs 5.4 months for zimberelimab alone.</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;font-style:italic;min-width:fit-content;">In 2022, Arcus and Gilead initiated several new clinical studies for domvanalimab, including two new registrational Phase 3 studies, for a total of four ongoing Phase 3 studies.</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;font-style:italic;min-width:fit-content;">Data from at least four clinical studies are anticipated in 2023, including updated ARC-7 data at the ASCO Annual Meeting in June and data from ARC-6 in prostate cancer and ARC-9 in colorectal cancer.</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;font-style:italic;min-width:fit-content;">Arcus is enrolling the second dose-escalation cohort (50mg) of ARC-20, a Phase 1/1b study of Arcus&#x2019;s small molecule HIF-2a inhibitor AB521; initial data for ARC-20 are anticipated in late 2023 or early 2024; a Phase 2 study evaluating AB521 in combination with other agents is anticipated for the second half of 2023.</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;font-style:italic;min-width:fit-content;">Arcus expects to submit IND filings for at least two molecules this year; Arcus also expects to advance its first molecule against an inflammation target, a highly selective KIT inhibitor, into the clinic by early 2024.</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;font-style:italic;min-width:fit-content;">With $1.1 billion in cash, cash equivalents, and marketable securities and funding into 2026, Arcus is well-positioned to advance its extensive pipeline.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">HAYWARD, Calif. &#x2013; (BUSINESS WIRE) &#x2013; Feb. 28, 2023 &#x2013;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today reported financial results for the fourth-quarter and full-year ended December 31, 2022 and provided a pipeline update on its six clinical-stage investigational molecules &#x2013; targeting TIGIT, the adenosine axis (CD73 and A2a/A2b receptors), HIF-2a and PD-1 &#x2013; across multiple common cancers.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#x201c;During 2022, Arcus established itself as a late-stage company and made tremendous progress in the advancement of its pipeline. This included the initiation of multiple registrational Phase 3 studies evaluating domvanalimab-based combinations versus standard of care, as well as the advancement of AB521, our HIF-2a inhibitor, into a Phase 1/1b study in patients,&#x201d; said Terry Rosen, Ph.D., chief executive officer of Arcus. &#x201c;Importantly, we also presented an interim analysis of ARC-7 data in December, demonstrating the potential for our domvanalimab-based combination to be a best-in-class anti-TIGIT/anti-PD-1 combination. In 2023, we expect multiple Phase 1b and Phase 2 clinical readouts and advancement into the clinic of at least two new drug candidates. With $1.1 billion in cash and runway into 2026, we are well-positioned to establish Arcus as a leader in the development of innovative therapies for lung and GI cancers.&#x201d;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Pipeline Highlights:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Domvanalimab (Fc-silent anti-TIGIT monoclonal antibody)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Domvanalimab Updates:</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:8.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">In 2022, Arcus and Gilead advanced their broad development strategy for domvanalimab, which now includes eight ongoing Phase 2 and Phase 3 studies evaluating domvanalimab-based combinations in non-small cell lung cancer (NSCLC) and upper gastrointestinal (GI) cancers. </font></div></div>
  <div style="margin-left:10.0%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:8.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.7033333333333336%;">o</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">The companies now have four ongoing registrational Phase 3 studies: three of the studies are in multiple NSCLC settings (ARC-10, STAR-121 and Pacific-8) and one study is in upper GI cancer (STAR-221).</font></div></div>
  <div style="margin-left:10.0%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:8.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.7033333333333336%;">o</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">There are also four ongoing Phase 2 studies to evaluate domvanalimab-based combinations: three in NSCLC and one in upper GI cancer.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Interim data from ARC-7, a 150-patient, randomized Phase 2 study evaluating the safety and efficacy of zimberelimab alone vs. domvanalimab plus zimberelimab (&#x201c;doublet&#x201d;) vs. domvanalimab plus zimberelimab and etrumadenant (&#x201c;triplet&#x201d;) in 1L PD-L1 &#x2265;50% metastatic NSCLC, were presented on December 20, 2022 at the ASCO Monthly Plenary Series.</font></div></div>
  <div style="margin-left:10.0%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.7033333333333336%;">o</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">At the time of data cutoff, efficacy was evaluated in patients who started treatment at least 13 weeks prior and were therefore potentially eligible for at least two imaging scans (n=133).</font></div></div>
  <div style="margin-left:10.0%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.7033333333333336%;">o</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">With a median follow-up time of approximately 12 months, a doubling of median progression-free survival (mPFS) was observed in each of the doublet and triplet arms, compared to zimberelimab monotherapy. The doublet and triplet arms demonstrated 12.0 months and 10.9 months mPFS, respectively, compared to 5.4 months observed in the zimberelimab monotherapy arm. </font></div></div>
  <div style="margin-left:10.0%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.7033333333333336%;">o</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">The doublet and triplet combinations demonstrated, respectively, a 45% and 35% reduction in risk of progression or death compared to zimberelimab monotherapy.</font></div></div>
  <div style="margin-left:10.0%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.7033333333333336%;">o</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">The domvanalimab-containing arms also demonstrated clinically meaningful improvements in six-month landmark PFS rates and objective response rate (ORR) compared to zimberelimab monotherapy. </font></div></div>
  <div style="margin-left:10.0%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.7033333333333336%;">o</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Safety was evaluated in all enrolled patients who received at least one dose (n=149). No unexpected safety signals were observed across the three study arms at the time of data cutoff. The domvanalimab-containing study arms appeared to be generally well tolerated and showed an overall safety profile consistent with the known safety profiles of each individual molecule to date.</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">During the fourth quarter, Taiho Pharmaceutical, Arcus&#x2019;s partner in Japan and other territories in Asia, opted to participate in two Phase 3 trials of domvanalimab combinations, STAR-121 in NSCLC and STAR-221 in upper GI cancer. Due to Taiho's participation, Arcus expects to receive certain milestone payments from Taiho in 2023.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Upcoming Domvanalimab Milestones:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">An updated analysis of the ARC-7 study, including efficacy evaluation for all 150 patients, is expected to be presented at the ASCO Annual Meeting in June 2023. </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Etrumadenant (A2a/A2b adenosine receptor antagonist)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Etrumadenant Updates:</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">In the fourth quarter, Arcus and Gilead initiated VELOCITY-Lung, a Phase 2 platform study, operationalized by Gilead, which is evaluating domvanalimab-, etrumadenant-, and zimberelimab-based combinations in advanced NSCLC. </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Upcoming Etrumadenant Milestones:</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Data from the randomized cohort of ARC-6, a Phase 1b/2 study evaluating etrumadenant plus zimberelimab and docetaxel versus docetaxel in metastatic castrate-resistant prostate cancer (CRPC), are expected in 2023. </font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Data from ARC-9, a Phase 1b/2 study evaluating etrumadenant-based combinations in 2L and third-line (3L) metastatic colorectal cancer (mCRC), are expected in 2023.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Quemliclustat (small-molecule CD73 inhibitor)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Quemliclustat Updates:</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">In the fourth quarter, Arcus and Gilead initiated EDGE-Lung, a Phase 2 platform study to evaluate domvanalimab-, quemliclustat-, and zimberelimab-based combinations in advanced NSCLC. </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Upcoming Quemliclustat Milestones:</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">In the first half of 2023, Arcus and Gilead expect PFS and OS data from all 90 patients in the ongoing Phase 1/1b ARC-8 trial evaluating quemliclustat plus chemotherapy with or without zimberelimab in first-line pancreatic cancer.</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Arcus and Gilead expect to initiate one or more cohorts with quemliclustat-based combinations in GI cancers in the ongoing Phase 2 ARC-21 study.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">AB521 (HIF-2a inhibitor)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Upcoming AB521 Milestones:</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:8.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">During the fourth quarter, Arcus completed Cohort 1 of ARC-20, a Phase 1/1b study of AB521 in cancer patients; at a dose level of 20 mg daily, deep reductions in serum erythropoietin were observed, which was consistent with observations from the ARC-14 study, evaluating AB521 in healthy volunteers.  </font></div></div>
  <div style="margin-left:10.0%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:8.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.7033333333333336%;">o</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Arcus is enrolling Cohort 2, evaluating a 50 mg daily dose, which Arcus believes may achieve greater drug levels than the marketed competitor. </font></div></div>
  <div style="margin-left:10.0%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:8.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.7033333333333336%;">o</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Initial data from ARC-20 are anticipated in late 2023 or early 2024.</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:8.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">A Phase 2 study evaluating AB521 in combination with other agents is anticipated for the second half of 2023.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Discovery Programs</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Arcus is on track to initiate a Phase 1 trial in cancer patients for AB598, its anti-CD39 antibody, in the first half of 2023. </font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Arcus plans to initiate a Phase 1 trial for AB801, a potent and highly selective Axl inhibitor, in 2023.  The early development plan is expected to focus on treatment-resistant tumor types, such as STK11-mutant NSCLC.</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Arcus expects to advance its first candidate against an inflammation target, AB375, a highly selective KIT inhibitor, into the clinic in early 2024.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Financial Results for the Fourth-Quarter and Full-Year 2022</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Cash, cash equivalents and marketable securities </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">were $1.1 billion as of December 31, 2022, compared to $681 million as of December 31, 2021. The increase was primarily due to the receipt of $725 million from Gilead in January 2022. Arcus expects cash utilization for 2023 to be between $300 million and $350 million. Its cash, cash equivalents and marketable securities on-hand is expected to be sufficient to fund operations into 2026.</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Revenues </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">were $34 million for the fourth-quarter 2022, compared to $355 million for the same period in 2021. In the fourth-quarter 2022, Arcus recognized $26 million in license and development service revenues for programs optioned by Gilead. Arcus further recognized $8 million in collaboration revenue related to Gilead&#x2019;s ongoing rights to access Arcus&#x2019;s research and development pipeline in accordance with the Gilead collaboration agreement. Revenues were $112 million for the full-year 2022, compared to $383 million for the same period in 2021.</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Research and Development (R&amp;D) Expenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> were $80 million for the fourth-quarter 2022, compared to $51 million for the same period in 2021. Arcus&#x2019;s expanding clinical and development activities increased costs by $60 million partially offset by $31 million in higher reimbursements for shared expenses from Arcus's collaborations, primarily the Gilead collaboration, which was expanded in December 2021. The $29 million increase in R&amp;D costs net of reimbursements was driven by Arcus's expanding clinical and development activities as Arcus enrolled more patients in its existing and new studies, which drove increases of $12 million in net clinical costs and $9 million in net manufacturing costs. Arcus's growing headcount drove a $5 million increase in net employee compensation costs.  For fourth-quarter 2022 and 2021, Arcus recognized gross reimbursements of $49 million and $18 million, respectively, for shared expenses from its collaborations, primarily the Gilead collaboration. For the full-year 2022 and 2021, R&amp;D expenses were $288 million and $257 million, respectively. This includes gross reimbursements of $161 million and $25 million, respectively, for shared expenses from Arcus's collaborations, primarily the Gilead collaboration, which was expanded in December 2021.</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">General and Administrative (G&amp;A) Expenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> were $28 million for the fourth-quarter 2022, compared to $23 million for the same period in 2021. The increase was driven by the increased complexity of supporting Arcus's expanding clinical pipeline and partnership obligations. Arcus's growing headcount and 2022 stock awards drove a $4 million increase in employee compensation costs, including a $2 million increase in non-cash stock-based compensation, as well as increases in office facilities due to the expansion of office space to support the higher headcount. G&amp;A expenses were $104 million for the full-year 2022, compared to $72 million for the same period in 2021.</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Net Income (Loss):</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> Net loss was $67 million for the fourth-quarter 2022, compared to a net income of $280 million for the same period in 2021. Net loss was $267 million for the full-year 2022, compared to a net income of $53 million for the same period in 2021.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Arcus Ongoing and Announced Clinical Studies</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:15.857%;"></td>
    <td style="width:23.806%;"></td>
    <td style="width:25.801%;"></td>
    <td style="width:20.602%;"></td>
    <td style="width:13.933%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Trial Name</font></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Arms</font></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Setting</font></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Status</font></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">NCT No.</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="5" style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Lung Cancer</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">ARC-7</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">zim vs. dom + zim vs. etruma + dom + zim</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">1L NSCLC (PD-L1 &#x2265; 50%)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Ongoing Randomized Phase 2</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">NCT04262856</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">PACIFIC-8</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">(Operationalized by AZ)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">dom + durva vs. durva</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Curative-Intent Stage 3 NSCLC</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Ongoing Registrational Phase 3</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">NCT05211895</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">ARC-10</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;dom + zim vs. pembro</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">1L NSCLC (PD-L1 &#x2265; 50%)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Ongoing Registrational Phase 3</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">NCT04736173</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">STAR-121</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">(Operationalized by GILD)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;dom + zim + chemo vs. pembro + chemo</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">1L NSCLC (PD-L1 all-comers)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Ongoing Registrational Phase 3</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">NCT05502237</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">EDGE-Lung</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">dom +/- zim +/- quemli +/- chemo</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">1L/2L NSCLC (lung cancer platform study)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Ongoing Randomized Phase 2</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">NCT05676931</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">VELOCITY-Lung</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">(Operationalized by GILD)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">dom +/- zim +/- etruma +/- sacituzumab govitecan-hziy or other combos</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">1L/2L NSCLC (lung cancer platform study)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Ongoing Randomized Phase 2</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">NCT05633667</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="5" style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Gastrointestinal Cancers</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">ARC-9</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">etruma + zim + mFOLFOX vs. SOC</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">2L/3L/3L+ CRC</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Ongoing</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Randomized Phase 2</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">NCT04660812</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">EDGE-Gastric</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">(ARC-21)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">dom + zim &plusmn; chemo</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">1L/2L Upper GI Malignancies</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Ongoing</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Randomized Phase 2</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">NCT05329766</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">STAR-221</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">dom + zim + chemo vs. nivo + chemo</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">1L Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma (EAC)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Ongoing Registrational Phase 3</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">NCT05568095</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="5" style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Pancreatic Cancer</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">ARC-8</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">quemli + zim + gem/nab-pac vs. quemli + gem/nab-pac</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">1L, 2L PDAC</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Ongoing Randomized Phase 1/1b</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">NCT04104672</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="5" style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Prostate Cancer</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">ARC-6</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">etruma + zim + SOC vs. SOC (also enrolling sacituzumab govitecan-hziy combination cohorts)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">2L/3L CRPC</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Ongoing Randomized Phase 2</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">NCT04381832</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="5" style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Various</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">ARC-12</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">AB308 + zim</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Advanced Malignancies</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Ongoing</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Phase 1/1b</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">NCT04772989</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">ARC-14</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">AB521</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Healthy Volunteers</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Ongoing</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">NCT05117554</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">ARC-20</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">AB521</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Cancer Patients / ccRCC</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Ongoing Phase 1/1b</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">NCT05536141</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">dom: domvanalimab; durva: durvalumab; etruma: etrumadenant; gem/nab-pac: gemcitabine/nab-paclitaxel; nivo: nivolumab; pembro: pembrolizumab; quemli: quemliclustat; SOC: standard-of-care; zim: zimberelimab</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">ccRCC: clear-cell renal cell carcinoma; CRC: colorectal cancer; CRPC: castrate-resistant prostate cancer; GI: gastrointestinal; NSCLC: non-small cell lung cancer; PDAC: pancreatic ductal adenocarcinoma</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> &#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">About the Gilead Collaboration</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">In May 2020, Gilead and Arcus entered into a 10-year collaboration that provided Gilead immediate rights to zimberelimab and the right to opt into all other Arcus programs arising during the collaboration term. In November 2021, Gilead and Arcus</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">amended the collaboration in connection with Gilead&#x2019;s option exercise for three of Arcus&#x2019;s then-clinical stage programs. For all other programs that are in clinical development or new programs that enter clinical development thereafter, the opt-in payments are $150 million per program. Gilead&#x2019;s option, on a program-by-program basis, expires after a specified period of time following the achievement of a development milestone for such program and Arcus&#x2019;s delivery to Gilead of the requisite qualifying data package. Concurrent with the May 2020 collaboration agreement, Gilead and Arcus entered into a stock purchase agreement under which Gilead made a $200 million equity investment in Arcus. That stock purchase agreement was amended and restated in February 2021 in connection with Gilead&#x2019;s increased equity stake in Arcus from 13% to 19.5%, with an additional $220 million investment.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Pursuant to the collaboration, Gilead and Arcus are currently co-developing and equally sharing global development costs for five clinical candidates, including: domvanalimab, an Fc-silent anti-TIGIT antibody; etrumadenant, a dual adenosine A2a/A2b receptor antagonist; quemliclustat, a small molecule inhibitor of CD73; and zimberelimab, an anti-PD1 antibody.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">About Arcus Biosciences</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Arcus Biosciences is a clinical-stage, global biopharmaceutical company developing differentiated molecules and combination medicines for people with cancer. In partnership with industry partners, patients and physicians around the world, Arcus is expediting the development of first- or best-in-class medicines against well-characterized biological targets and pathways and studying novel, biology-driven combinations that have the potential to help people with cancer live longer. Founded in 2015, the company has expedited the development of six investigational medicines into clinical studies, including new combination approaches that target TIGIT, PD-1, the adenosine axis (CD73 and dual A2a/A2b receptor) and HIF-2a. For more information about Arcus Biosciences&#x2019; clinical and pre-clinical programs, please visit www.arcusbio.com or follow us on Twitter.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Domvanalimab, etrumadenant, quemliclustat, and zimberelimab are investigational molecules, and neither Gilead nor Arcus has received approval from any regulatory authority for any use globally, and their safety and efficacy have not been established. AB521 and AB598 are also investigational molecules, and Arcus has not received approval from any regulatory authority for any use globally, and their safety and efficacy have not been established.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Forward-Looking Statements</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">This press release contains forward-looking statements. All statements regarding events or results to occur in the future contained herein, including, but not limited to, the statements in Dr. Rosen&#x2019;s quote, Arcus&#x2019;s expectation that its cash, cash equivalents and marketable securities on-hand are sufficient to fund operations into 2026, future data disclosures and presentations, the projected achievement of clinical study milestones and their associated timing (including under the captions &#x201c;Upcoming Domvanalimab Milestones,&#x201d; &#x201c;Upcoming Etrumadenant Milestones,&#x201d; &#x201c;Upcoming Quemliclustat Milestones,&#x201d; and &#x201c;Upcoming AB521 Milestones&#x201d;), additional clinical studies in planning or expected to be initiated (including under the caption &#x201c;Discovery Programs&#x201d;), and the receipt and timing of milestone payments from Taiho are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All forward-looking statements involve known and unknown risks and uncertainties and other important factors that may cause Arcus&#x2019;s actual results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: risks associated with preliminary and interim data not being guarantees that future data will be similar; the unexpected emergence of adverse events or other undesirable side effects; difficulties or delays in initiating or conducting clinical trials due to difficulties or delays in the regulatory process, enrolling subjects or manufacturing or supplying product for such clinical trials, all of which may be exacerbated by the COVID-19 pandemic; Arcus&#x2019;s dependence on the collaboration with Gilead for the successful development and commercialization of its optioned molecules; difficulties associated with the management of the collaboration activities or expanded clinical programs; changes in the competitive landscape for Arcus&#x2019;s programs; and the inherent uncertainty associated with pharmaceutical product development and clinical trials. Risks and uncertainties facing Arcus are described more fully in its Annual Report on Form 10-K for the year ended December 31, 2022, filed on February 28, 2023 with the SEC. You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this press release. Arcus disclaims any obligation or undertaking to update, supplement or revise any forward-looking statements contained in this press release except to the extent required by law.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">The Arcus name and logo are trademarks of Arcus Biosciences, Inc. All other trademarks belong to their respective owners.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Investor Inquiries:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"><br>Pia Banerjee	<br>Head of Investor Relations &amp; Strategy<br>(617) 459-2006<br></font><font style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">pbanerjee@arcusbio.com</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Media Inquiries:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"><br>Holli Kolkey<br>VP of Corporate Communications<br>(650) 922-1269<br></font><font style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">hkolkey@arcusbio.com</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ARCUS BIOSCIENCES, INC.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements of Operations</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(unaudited)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (In millions, except per share amounts)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:48.279%;"></td>
    <td style="width:1.251%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:9.544%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.251%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:9.594000000000001%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.251%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:9.644%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.251%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:9.934000000000001%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Three Months Ended<br>December 31,</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Years Ended<br>December 31,</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Revenues:</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">License and development service revenue</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">345</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">345</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other collaboration revenue</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total revenues</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">355</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">112</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">383</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating expenses:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">51</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">288</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">257</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">72</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total operating expenses</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">108</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">392</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">329</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income (loss) from operations</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(74</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">281</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(280</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">54</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-operating income (expense):</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest and other income, net</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effective interest on liability for sale of future royalties</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(1</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(2</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total non-operating income, net</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income (loss) before income taxes</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(67</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">282</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(266</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income tax expense</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(2</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(1</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(2</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net income (loss)</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(67</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">280</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(267</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net income (loss) per share:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Basic</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(0.93</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.97</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(3.71</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.76</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Diluted</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(0.93</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.71</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(3.71</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.71</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares used to compute net income (loss) per share:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Basic</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">72.6</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">70.4</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">72.0</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">69.3</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Diluted</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">72.6</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75.4</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">72.0</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74.0</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Selected Consolidated Balance Sheet Data</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(unaudited)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (In millions)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.199%;"></td>
    <td style="width:1.702%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.197%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.702%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.197%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash, cash equivalents and marketable securities</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,138</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">681</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total assets</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,345</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,592</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total liabilities</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">688</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">750</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total stockholders&#x2019; equity</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">657</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">842</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img230044022_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img230044022_0.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %Z!#L# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_/[_@JO\6C8Z/X5^'5
ME.4FO'.L:@J,0?*7=' I]0S^:V/6)37Z ,P522< <DFOPP_:A^*Q^-'QU\6>
M)XI?-TZ6Z-MI_/'V6+]W$0.VY5WD>KFO=R>A[7$<[VCK\^AC5E:-CR_[1)_?
M?\S1]HD_OO\ F:CYHYK[LXB3[1)_??\ ,U]#_L%_%Q_A?^T=X?%U<LFE:_G1
M;L,WR_O2/*;T&)5CY[*6KYTYIT,SV\J2Q.T<J,&5T."I'((/8UC6I*M3E3EL
MT4G9W/Z(J*\X_9W^*,?QE^"_A/Q=O5KF^LU6\"\!;E"8YACL/,5L>Q%>CU^8
M3BZ<G"6Z/0WU"BBBH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >!_MP?
M%C_A4G[.?B6\@F\G5=60:-8$'!\R8$.P/8K$)6!]5%?BOS7VW_P5)^+'_"2_
M%31O UI-NL_#=KY]TJG@W4X#8/KMB$9'_71A7Q)S7WV4T/8X92>\M?\ (XJL
MKR#FCFCFCFO:,0YHYHYHYH _17_@E)\5MT7BSX<W<W*D:UIZL>QVQ3J/_()
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M%O,+<VV<#./XTR<!UXY .#Q7KE?,5*<J<G":LT="=]4%%%%9C"BBB@ HHHH
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MRC)QG&#V)KOZ_GL\/>)-5\(ZQ;:MHFHW6DZG;-OAN[.5HI8SZAE.:^T? _\
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MRJG_ '5%>W45\E7S#$XA^]*R[+0ZE",>A7L=/M=+MUM[.VAM+=?NQ01A%'T
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MO3AS:LT_#_A_3?">B66CZ-8P:;I=E$(;>TMD"1Q(.@ %:-%%?":O5G8%%%%
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MG460D$6L0WR#(Z%@ @/8N*_<BSLX-/M(+6UACMK:!%BBAA4*D:*,*J@<
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M'IN!\QNGWU!'R"OK&FHBQJJ(H55& JC  IU?F5>M+$5)59;L]&*Y59!1116
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M4 %%%% !1110 4444 %?D5_P4V_Y.>G_ .P1:?\ L]?KK7Y%?\%-O^3GI_\
ML$6G_L]>]DO^]?)_H8UOA/E#FCFCFCFONCB.A^'?_)0/#/\ V%+7_P!'+7]
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MV,H3'DR(JCYWVDJ=S+PB>E1?#G_@EY\,_"YCG\4:AJGC*Z4@M&[_ &.V./\
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M/_HIZ_;:OQ)_8H_Y.F^'7_80/_HIZ_;:OE\\_CQ]/U9T4?A"BBBOG#<****
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M&7FOLS_@J!\5_P#A+OC-I_@ZTFWV'A>TQ,JG@W<X5WZ=<1B$>QWBOC/FOO\
M*:'L<,F]Y:_Y'%4E>0<U]-_\$[_A7_PLC]H[2K^YA\S3/#,;:Q,6'RF5"%@&
M?7S&5Q[1FOF3FOU@_P""8OPK_P"$-^!MUXJN8=FH>*KLS(Q&#]EA+1Q _5_.
M;W#K6N95_88:36[T7S_X J:YI'V)1117YV=P4444 %%%% !113))$AC:21E2
M-069F.  .I)H ?7S-_P4(^$/_"TOV>=4O;6'S-8\,M_;%L5'S&) 1<)GT\LL
M^.YC6KWQ<_;V^$GPG\ZU&MGQ5J\>1]AT +< ,.S2Y$:\]?F)&#Q7Q?\ %C_@
MIY\0O&4=S8^%-,T_P?ILJM'YC*+RZ93QRSC8./1.,]:]G!8+%.I&K"-K=]/^
M"93G&UF?&W-'-'-'-??G"'-'-'-'- %R36=0FTV+3Y+ZY>PA),=JTS&)"3DD
M+G R>>E4^:EL[<WE[;6PDCA:XF2!9)FVQJ78*"Q[*"1D]A7TSHW[!?B*1Q_;
M?B_2[ ?Q1V%M)<,/HS%5/Y5X&:9[EF1J+S"LJ?->VC;=M[))OJCT,+@,3CFU
MAX<UM]OU/F'FCFOM;2/V#_!]OC^TO$>O:HW=8O*M@?\ OE2?UKN]#_8=^'JA
M?*\):OJQ];F\N)0?^^<"OBJGB5D2?+052H_[L/\ Y)Q?X'MQX:Q]KU.6/J_\
MKGYW9]::TB]V4?4U^HVG?L1^$(\&'X5:>?>Y1B?_ !]ZZ.S_ &,=!10%^&_A
MN$?[<$)_J:R_XB#"?\'+Z[_[=2_5A_8/+\>)IKYGY+>8A_C7\ZZ_X/L#\6O!
M.#G_ (GEE_Z4)7ZCK^Q;H,BX;P+X44'UM8_Z+5G1?V*/#&F:]INICP7X7AFL
M[J*X26&$JZ,CA@RX7J".*VCQO.I[KRZJK_X?\T92R>G%76)@_O/J>BBBLCS
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M"_[!OP.\*LKQ>!X-2F4Y\S5+F:YS]4=]G_CM>T^&_"&A>#K,6F@Z+I^B6O\
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M:^L/*&R1K-&R-G:P*G!P:_9?]CF[\-_%WX!^%O$,]DEYK$, T[4FGD+G[1
MC,1]T;U"R8QP)!UK\:N:^\_^"5/Q6_LOQAXF^'UY-B#58!JEBK'@3Q8655'J
MT95OI#7S6?9=0QV'4ZU-2=/572=K[VO\ON.W#8BK0DU3DXWWL['Z26>C6&G
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M[#MDQZQBO/Q]#ZQAY06^Z^1I"7+*Y^XM%-5ED565@RL,A@<@BG5^;G>%%%%
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M0*?%KX0Q>&-3N0_B;PJB6D@=OGGL\8@E'K@#RVZ\HI)^<5]85^#?P)^,VL?
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M+7] =?S]?#^01>/?#;M]U=3MB?PE6OZ!:^1S[XJ?S_0ZZ/4****^5.@****
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M444 %%%% !1110 45!>7EOI]K-=7<\=M;0J7DFF<(B*.26)X 'J:^)?VDO\
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M?5G>%%%% !7Y2?\ !4KPG_8_Q\TG6D7$6L:+$S-CK+%(\;?^.>57ZMU\$_\
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M:B_9UTK]I'X:W&A71CM-;M2UQI&I,.;:?&,,1SY;X"L.>QQE5K\4?%?A75?
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M[17XO:+^WU\==#C")XYDNT QMO;&VF/_ 'TT>[]:UYO^"CGQUD3:OB:RB/\
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M@AXJ_P# ^'_XQ1_PZU^#_P#T$/%7_@?#_P#&*/[9POG]P>RD?D[S1S7ZQ?\
M#K7X/_\ 00\5?^!\/_QBC_AUK\'_ /H(>*O_  /A_P#C%']LX7S^X/92/R=Y
MHYK]8O\ AUK\'_\ H(>*O_ ^'_XQ1_PZU^#_ /T$/%7_ ('P_P#QBC^V<+Y_
M<'LI'Y.\T<U^L7_#K7X/_P#00\5?^!\/_P 8H_X=:_!__H(>*O\ P/A_^,4?
MVSA?/[@]E(_)WFOWU^#W_)(_!'_8#L?_ $G2OFS_ (=:_!\_\Q'Q5_X'P?\
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M_!__ *"'BK_P/A_^,4?VSA?/[@]E(_)WFCFOUB_X=:_!_P#Z"'BK_P #X?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P"&V?@G_P!#Y:_^ ES_ /&J /<**\T^'W[2'PW^*GB Z)X5\40:OJGDM/\
M9XX)D.Q2 S9= .,COWKTN@ HHHH ***IZQJUIH.DWNIZA.+:PLH'N;B9@2(X
MT4LS''/ !- %RBO#_P#AMGX)_P#0^6O_ ("7/_QJO7O#GB/3/%VA6.M:->Q:
MCI=]$L]O=0G*R(>A]O<'D$$'F@#2HHHH **** "BN"^)7QT\"_!^XL(/&'B&
M'1);Y7>W66&5_,52 Q^16Q@L.OK5[X;_ !;\(_%[3;N_\(:U'K5I:R^1-)''
M(FQ]H;&'4'H10!U]%%% !1110 4444 %%%<;\0OC%X*^%-J)_%GB2PT4,,I#
M-)F:0>JQ+EV_ &@#LJ*^1/%'_!3#X::3*T6D:5KVND?\MD@2"(_0N^[_ ,=K
MF$_X*E^'3-A_ >IK%_>6^C+?EM'\Z8'W%17RUX-_X*-?"?Q)-'#J3:MX9D8X
MWZA:;X@?]Z)G./<@5]&>%?&6A>.M)34_#VL66M6#]+BQG65<^A(/!]CS2 V:
M*** "BBB@ HHK!\;^.-#^''AF[\0>)-032]'M2@FNI$9@F]PB\*">68#@=Z
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M *635\+_ /!0[_DYK5_^O"S_ /10K[H_87_Y-7\#_P"Y=_\ I9-3 ]YHHHI
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MT^\U:WMKBVN$#I+&[A64@^H)K:_:8^!>H?L\_%2ZTA3,VD3M]LT>_)P9("W
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M^A^T_P#[]S?_ !% 'M%%<SX ^)'AGXI:(^L>%=7AUK38YVMFN( P D4*2IW
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M]V.-,_4L?_9:[^&Z?M<VH1\[_<F_T./.9^SP%5^5OO:1[)1117]('XX%%%%
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M_10K[H_87_Y-7\#_ .Y=_P#I9-7PO_P4._Y.:U?_ *\+/_T4*^Z/V%_^35_
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M.^#KSX>_"OPIX9U"6">^TG38;.:2V),;.B $J2 2..X%=C10 4444@"BBB@
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MA[2*._\ $HW#^(+[_P#L?_MV6NCZ;9>"/B5>F*WMU6'3O$,N6"H.%BN#U '
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M_P#);/A__P!C#I__ *4QU^T/C[_D1/$?_8-N?_135^+OP-_Y+7\/O^QAT_\
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M,?\ P3S&@WUGXF^**6]W<Q$2V_AN-A)$C#D&X8?*^/\ GFN5]2PRM?=( 48
MP*6BI **** "BBB@#\GO^"AW/[36K\?\N%G_ .BA7W/^PO\ \FK^!^WR7?\
MZ635[K):PR-N>*-V]64$T](UC4*BA%'0*,"F ZBBBD 4444 8'C[_D1?$?\
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,%4 "KU( HHHI ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>4
<FILENAME>rcus-20230228_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-02-28T15:54:08.2716+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="rcus-20230228.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>rcus-20230228.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-02-28T15:54:08.2184+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://arcusbio.com/20230228" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:rcus="http://arcusbio.com/20230228" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" namespace="http://fasb.org/us-gaap/2022"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rcus-20230228_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rcus-20230228_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>
      <link:roleType roleURI="http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>rcus-20230228_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-02-28T15:54:08.2622+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Act File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139906263320512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 28,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Arcus Biosciences, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001724521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Securities Act File Number</a></td>
<td class="text">001-38419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-3898435<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3928 Point Eden Way<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Hayward<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94545<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(510)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">694-6200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, Par Value $0.0001 Per Share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RCUS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>rcus-20230228_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rcus-20230228.xsd" xlink:type="simple"/>
    <context id="C_df0de228-4cd4-4905-a604-0c5db05d905c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001724521</identifier>
        </entity>
        <period>
            <startDate>2023-02-28</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c"
      id="F_376ebc41-c3a9-4a1b-b5dd-5a5ac30bb478">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c"
      id="F_72021a59-91a5-44b2-a3e9-aec87a77cd4d">0001724521</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c"
      id="F_6534ed74-9d1d-42c2-9130-786096a7abfa">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c"
      id="F_a990aa1f-07ce-49ee-ba02-ecc46b7ba072">2023-02-28</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c"
      id="F_713aa355-3333-4ede-b612-259e9760613b">Arcus Biosciences, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c"
      id="F_1c073011-e8d4-4acf-a57e-3c10a85c4d6e">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c"
      id="F_10ad603a-ab8a-45d6-9691-0aef2320fb75">001-38419</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c"
      id="F_b8284580-b402-4432-b01e-50bfaafcf9e1">47-3898435</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c"
      id="F_9fad0802-319b-4e28-ae57-cfe47a6d1289">3928 Point Eden Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c"
      id="F_d652d015-db40-4fda-8ddf-c5c08fd28b15">Hayward</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c"
      id="F_5a48de26-8b01-43b5-a95f-c6def6a1666c">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c"
      id="F_aa2994bc-390a-44f6-a3b8-78e49968c740">94545</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c"
      id="F_55592e08-7811-4cb0-a3c0-bd75e4672bdd">(510)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c"
      id="F_57f07c3e-7d64-46ca-a628-82233055c2b4">694-6200</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c"
      id="F_a29ae567-a275-4a1e-a7b1-609750ce0467">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c"
      id="F_c861aeef-9b1b-4f0c-8df1-a507b9fea128">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c"
      id="F_289e2376-110c-400a-8706-d539a44faa82">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c"
      id="F_ebd88478-02bc-4d4e-8823-86fc0a920fe8">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c"
      id="F_09c6f262-c435-4c1d-95b3-da753fa8b488">Common Stock, Par Value $0.0001 Per Share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c"
      id="F_d4e2a01f-1439-4744-9d06-6ecfb7159a64">RCUS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c"
      id="F_4d97c5fb-cb2e-42b1-af6a-d0e4017dd05d">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_df0de228-4cd4-4905-a604-0c5db05d905c"
      id="F_c89bfc35-e03d-43b3-91de-17034fe87d93">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MVK3:O0_O3HS,RW?0A33X1EL>KH%CO=D;\/NEE.;UQ+[65O^5&/\#4$L#!!0
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MDUM)Z.#<@V#OX96,'<V/'W?W U!+ P04    " !=@5Q6)!Z;HJT   #X 0
M&@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I
M0P5,75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LID
MR^SO *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\
M./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6
M?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ 78%<5F60>9(9 0
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M<',O87!P+GAM;%!+ 0(4 Q0    ( %V!7%95#A*([@   "L"   1
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M96QS+RYR96QS4$L! A0#%     @ 78%<5CJJHN=  0  / (   \
M     ( !9Q   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( %V!7%8D'INB
MK0   /@!   :              "  =01  !X;"]?<F5L<R]W;W)K8F]O:RYX
M;6PN<F5L<U!+ 0(4 Q0    ( %V!7%9ED'F2&0$  ,\#   3
M  "  ;D2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(   ,4
$      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="rcus-20230228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="rcus-20230228.htm">rcus-20230228.htm</File>
    <File>rcus-20230228.xsd</File>
    <File>rcus-20230228_lab.xml</File>
    <File>rcus-20230228_pre.xml</File>
    <File>rcus-ex99_1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "rcus-20230228.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "rcus-20230228.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rcus-20230228_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rcus-20230228_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "rcus-20230228.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "rcus",
   "nsuri": "http://arcusbio.com/20230228",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "rcus-20230228.htm",
      "contextRef": "C_df0de228-4cd4-4905-a604-0c5db05d905c",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document And Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "rcus-20230228.htm",
      "contextRef": "C_df0de228-4cd4-4905-a604-0c5db05d905c",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Securities Act File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://arcusbio.com/20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0000950170-23-005084-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-23-005084-xbrl.zip
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MOA,_G13$H7S0W [2_=<HRWDTV0$U=)Z@I?.[#] #Q]^"?Y"-0-X3$/VR0I(
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M$?4/UK,1U3%EGQO'^8LW#0\*1<]>D&0B"S58>KLLGK 6 3"_$FD-1*RO@VP
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M&WR#QH8B1IX:@4 \'&2 .V)Y+=B_SJ^F'*3'&)1&NHEL6&]2(!:".D&=H%Z
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MFD])^AF'.O!ET?%2Q-LND4?4XM6O[@M7&6]P#&\0H4[$5R+XL^+$D;T/+KP
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M4I[7XU'S27HDSB?.WUW.+X#WK #>O8OO^3CHGNVS]Q!) 5-%V^ 54BHYJK_
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MQ/>1A2X$DA=J]0-RIE.O_BO7H)[B88H^9^ T]#R*IE/!P*$!@0.HNZ]OS M
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MP9 'LI422X2:;1 W>:!U>Z!6BY"T<22]?J7!-I7=2N-,:)+'>K1 DSSLGDM
MDSQ(,<1AQ&$$%5+,%BB&.(PXC*!"BBFS8HC#B,,(*J086C!@>>'2C@4#,;]E
MXC80?B3LJ/38I5<[$&C9?E&TD1MMY+9SY=*7GH-%&[GM%$+M$CBY+W)?%H&#
MW-<&YYN6 )FV^R^:GDH.T!*F)0=HI5K( 5KK &DG;G* Y #) 9(#) >XDPZ0
M,L!==(#+/<O",5):S5D63D$%Y#1I[I ]6J"Y0W9/4:&Y0Z08XC#B,((**68+
M%$,<1AQ&4"'%E%DQQ&'$80054@RM0[%\?'K#98G/(L[.J3"'5]A1J+)+K78
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M"BFF%(HA#B,.(ZB08LJL&.(PXC"""BG&_@44VS1F5K[1_TL\X2)B223Z+%;
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M/_['#^]&\=C[\?\#4$L! A0#%     @ 78%<5HCW?J>A$P  ;NH  !$
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H(0  <F-U<RUE>#DY7S$N:'1M4$L%!@     %  4 00$  -%8      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
